Stay updated with breaking news from Mo Khan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hvivo, formerly known as Open Orphan , is at the very heart of the latest advances - not as a vaccine maker, but helping drug developers assess the efficacy of their RSV treatments.
Hvivo, formerly known as Open Orphan , is at the very heart of the latest advances - not as a vaccine maker, but helping drug developers assess the efficacy of their RSV treatments.
HVIVO PLC (AIM:HVO) chief executive Mo Khan says "contract values seem to be increasing" for human challenge studies as he updated Proactive after signing a...
Open Orphan to hold a Capital Markets Day on 2 November 2022
Investegate announcements from Open Orphan PLC, CFO appointment & change of Board roles